in the development, production of micro-implants ensuring a controlled release of drugs in Ophthalmology
We are the exclusive Bausch & Lomb’s Surgical products Distributor for Belgium and Luxemburg
Thanks to our technology, we are committed to provide developing countries populations, where glaucoma is the second cause of blindness, with unique treatments
EyeD Pharma manages the entire process, from the idea to the market including product development, manufacturing, non-clinical and clinical studies
EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.
We also distribute surgical products to ophthalmologists who need the highest quality of products for their clinical practice.
EyeD Pharma is born to the combination of the clinical expertise of Prof. Jean-Marie Rakic and the entrepreneurial experience and polymer expertise of Prof Jean-Michel Foidart, Melanie Mestdagt and Marc Foidart.
EyeD Pharma was founded to answer to unmet clinical needs in ophthalmology by offering patients intra-ocular implants able to release drugs in a very precisely controlled way for several years to remove compliance issue and avoid degradation of the pathology.
EyeD Pharma becomes exclusive distributor of Bausch & Lomb‘s surgical products in Belgium and Luxembourg.
EyeD Pharma aims to become a leader in the development, production and commercialization of micro-implants ensuring a controlled release of drugs in Ophthalmology to find solutions to unmet medical needs in ocular pathologies.
EyeD Pharma’s unique value proposal relies on a fully integrated approach with a technological platform and expertises allowing the development from idea to market authorization, including manufacturing.
Our product candidates are based on innovative drug delivery system, well known API’s and based on medical unmet need advised by internationally renowned key opinion leaders. Our innovative drug products are designed to ensure a full compliance of the patient while drastically reducing or even eliminating side-effects and avoiding degradation of the pathology.
Our technological platform allows several applications outside of our internal focus on ophthalmology. This includes treatments to be addressed locally in very small parts of the human body (like ear-throat-nose, oncology, neurology…), on a stand-alone basis or through dedicated partnerships.
EyeD Pharma manages the entire development process from the idea to the market including product development, non-clinical & clinical studies. Our development, clinical and commercial batches are produced on our internally developed specific production process.
EyeD Pharma has a multidisciplinary team combining advanced expertise in chemistry, industrial process, pharmaceutical development, controlled release, regulatory affairs, preclinical, clinical, financial and business fields.
Our sales department also has a strong expertise (more than 20 years) in ophthalmic surgery.
Du 8 au 10 Octobre, en partenariat avec la société Bausch & Lomb, l’équipe d’EyeD Pharma est heureuse de pouvoir vous rencontrer lors de la 39ème édition du congrès ESCRS qui se déroulera au RAI d’Amsterdam.
Van 8 tot 10 oktober is het EyeD Pharma team, in samenwerking met de firma Bausch & Lomb, verheugd om u te ontmoeten naar aanleiding van de 39ste editie van het ESCRS dat plaatsvindt in de RAI in Amsterdam.